AI-driven analysis by identifying risk factors of VL relapse in HIV co-infected patients

利用人工智能驱动的分析,识别HIV合并感染患者内脏利什曼病复发的风险因素

阅读:3

Abstract

Visceral Leishmaniasis (VL), also known as Kala-Azar, poses a significant global public health challenge and is a neglected disease, with relapses and treatment failures leading to increased morbidity and mortality. This study introduces an explainable machine learning approach to predict VL relapse and identify critical risk factors, thereby aiding patient monitoring and treatment strategies. Leveraging data from a follow-up study of 571 patients, the survival machine learning models are applied, including Random Survival Forest (RSF), Survival Support Vector Machine (SSVM), and eXtreme Gradient Boosting (XGBoost), for relapse prediction. The results demonstrated that RSF, with a C-index of 0.85, outperformed the conventional Cox Proportional Hazard (CPH) model (C-index 0.8), offering improved prediction capabilities by capturing non-linear relationships and variable interactions. To address the lack of transparency (in terms of feature importance) in Machine Learning (ML) models, the SHapley Additive exPlanation (SHAP) method is employed, which enhances model interpretability (feature importance) through visual insights. SHAP dependence plots allowed the healthcare professionals to evaluate which factors encourage the occurrence of the relapse. A statistically significant relationship between HIV co-infection (HR=3.92, 95% CI=2.03-7.58) and VL relapse was identified through -2 log-likelihood ratio and chi-square tests. These results indicate the promise of explainable artificial intelligence (XAI) for making clinical decisions and remedying recurrences in VL.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。